228 related articles for article (PubMed ID: 21503121)
1. [Correlation between levels of serum growth differentiation factor-15 and acute coronary syndrome].
Zheng LB; Guo YH; Yu HY; Mi L; Wang YP; Gao W
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):250-4. PubMed ID: 21503121
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor-15 levels and the risk of contrast induced acute kidney injury in acute myocardial infarction patients treated invasively: A propensity-score match analysis.
Sun L; Zhou X; Jiang J; Zang X; Chen X; Li H; Cao H; Wang Q
PLoS One; 2018; 13(3):e0194152. PubMed ID: 29529072
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy.
Tentzeris I; Farhan S; Freynhofer MK; Rohla M; Jarai R; Vogel B; Baumgartner-Parzer S; Nürnberg M; Geppert A; Wessely E; Wojta J; Huber K; Kautzky-Willer A
Am J Cardiol; 2017 Sep; 120(5):747-752. PubMed ID: 28734463
[TBL] [Abstract][Full Text] [Related]
4. Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.
Zhang B; Peng W; Li H; Lu Y; Zhuang J; Wang K; Su Y; Xu Y
Clin Biochem; 2013 Oct; 46(15):1520-5. PubMed ID: 23850850
[TBL] [Abstract][Full Text] [Related]
5. Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
Damman P; Kempf T; Windhausen F; van Straalen JP; Guba-Quint A; Fischer J; Tijssen JG; Wollert KC; de Winter RJ; Hirsch A;
Int J Cardiol; 2014 Mar; 172(2):356-63. PubMed ID: 24502880
[TBL] [Abstract][Full Text] [Related]
6. Different characteristics of cardiac biomarkers to decide and predict the culprit lesions in patients with suspicious acute coronary syndrome.
Kitamura M; Hata N; Takayama T; Hirayama A; Ogawa M; Yamashina A; Mera H; Yoshino H; Nakamura F; Seino Y
Heart Vessels; 2016 Jun; 31(6):907-17. PubMed ID: 26081026
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial.
Wallentin L; Lindholm D; Siegbahn A; Wernroth L; Becker RC; Cannon CP; Cornel JH; Himmelmann A; Giannitsis E; Harrington RA; Held C; Husted S; Katus HA; Mahaffey KW; Steg PG; Storey RF; James SK;
Circulation; 2014 Jan; 129(3):293-303. PubMed ID: 24170388
[TBL] [Abstract][Full Text] [Related]
8. Growth differentiation factor-15 levels and the risk of contrast induced nephropathy in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A retrospective observation study.
Sun L; Zhou X; Jiang J; Zang X; Chen X; Li H; Cao H; Wang Q
PLoS One; 2018; 13(5):e0197609. PubMed ID: 29791474
[TBL] [Abstract][Full Text] [Related]
9. Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study.
Kempf T; Sinning JM; Quint A; Bickel C; Sinning C; Wild PS; Schnabel R; Lubos E; Rupprecht HJ; Münzel T; Drexler H; Blankenberg S; Wollert KC
Circ Cardiovasc Genet; 2009 Jun; 2(3):286-92. PubMed ID: 20031597
[TBL] [Abstract][Full Text] [Related]
10. Relationship between resistin level in serum and acute coronary syndrome or stable angina pectoris.
Qiao XZ; Yang YM; Xu ZR; Yang LA
J Zhejiang Univ Sci B; 2007 Dec; 8(12):875-80. PubMed ID: 18257120
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings.
Brunetti ND; Troccoli R; Correale M; Pellegrino PL; Di Biase M
Int J Cardiol; 2006 May; 109(2):248-56. PubMed ID: 16055214
[TBL] [Abstract][Full Text] [Related]
12. Long-term prognostic value of growth differentiation factor-15 in acute coronary syndromes.
Peiró ÓM; García-Osuna Á; Ordóñez-Llanos J; Cediel G; Bonet G; Rojas S; Quintern V; Bardají A
Clin Biochem; 2019 Nov; 73():62-69. PubMed ID: 31369736
[TBL] [Abstract][Full Text] [Related]
13. [Plasma matrix metalloproteinases-2 and -9 levels are elevated in patients with acute coronary syndrome and coronary chronic total occlusion].
Tang QD; Wu PS; Hou YQ; Huang Z; Zhou ZJ; Guo ZG; Xiu JC; Wang YG
Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):1004-7. PubMed ID: 19460733
[TBL] [Abstract][Full Text] [Related]
14. Association of Growth Differentiation Factor 15 with Arterial Stiffness and Endothelial Function in Subpopulations of Patients with Coronary Artery Disease: A Proof-of-Concept Study.
Mourouzis K; Siasos G; Bozini N; Oikonomou E; Zaromitidou M; Tsigkou V; Kokkou E; Bletsa E; Stampouloglou P; Vavuranakis M; Tousoulis D
Recent Adv Inflamm Allergy Drug Discov; 2022; 16(2):107-115. PubMed ID: 36336806
[TBL] [Abstract][Full Text] [Related]
15. Relationship between serum vasoactive factors and plaque morphology in patients with non-ST-segment elevated acute coronary syndrome.
Lu YF; Lü SZ; Chen YD
Chin Med J (Engl); 2010 Jan; 123(2):193-7. PubMed ID: 20137369
[TBL] [Abstract][Full Text] [Related]
16. The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase-myocardial band.
Ruzgar O; Bilge AK; Bugra Z; Umman S; Yilmaz E; Ozben B; Umman B; Meric M
Heart Vessels; 2006 Sep; 21(5):309-14. PubMed ID: 17151819
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of serum calprotectin level with the range of coronary lesion in patients with acute coronary syndrome].
Fang H; Xie N; Qin L; Xia K; Fang F; Yang T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 39(9):912-6. PubMed ID: 25269499
[TBL] [Abstract][Full Text] [Related]
18. Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study.
Farhan S; Freynhofer MK; Brozovic I; Bruno V; Vogel B; Tentzeris I; Baumgartner-Parzer S; Huber K; Kautzky-Willer A
Cardiovasc Diabetol; 2016 Apr; 15():60. PubMed ID: 27056183
[TBL] [Abstract][Full Text] [Related]
19. The role of growth differentiation factor 15 as a predictor of 5-year survival of patients after acute coronary syndrome.
Vyshnevska IR; Kopytsya MP; Kutya IM; Protsenko OS
Pol Merkur Lekarski; 2020 Oct; 48(287):297-301. PubMed ID: 33130786
[TBL] [Abstract][Full Text] [Related]
20. Effect of Serum Growth Differentiation Factor-15 and the Syntax Score on 2-Year Outcomes in Patients With Acute Coronary Syndrome.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Avanzas P; Consuegra-Sanchez L
Am J Cardiol; 2016 May; 117(10):1569-1574. PubMed ID: 27013387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
